1300022I university of maryland, baltimore; vteu; task order: 14-0031.B1C1D1.0022--22; base

Ended Awarded Last action

Contract number
HHSN27200010
Awardee
Awarding agency
Obligated
$2,549,095

Award facts

Opportunity
Contract value 100% obligated
$2,549,094.56 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Baltimore, MD 21201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00010 -$17,292
Funding Only Action P00009 -$154,254
Other Administrative Action P00008 $0
Funding Only Action P00007 $700,103
Funding Only Action P00006 · UMB vaccine treatment evaluation units (vteus), to 10, protocol 14-0031 protocol development, implementation, and assays. -$1,841,421
Funding Only Action P00005 -$32,457
Other Administrative Action P00004 $0
Exercise an Option 3 $1,171,593
Other Administrative Action 2 · Vaccine treatment evaluation units (vteus) $0
Other Administrative Action 1 · The purpose of this modification is to grant extension to the task area b until april 29, 2016, and update various articles and clauses $0
Original award $2,722,822
Show all 11

About this award

Written by GovTribe AI ·

This is a federal contract award to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) program, administered by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract has a ceiling value of $2,549,094.56 and was awarded on July 2, 2015, with a performance period ending on December 31, 2022. The contract was issued as a delivery order under the VTEU indefinite delivery, indefinite quantity (IDIQ) contract vehicle. No set-aside designation was used for this award. UMB, as a state-controlled institution of higher learning, is the prime contractor, and the award supports the university's research capabilities across multiple disciplines, including infectious disease studies and clinical trials.

Quick answers

Who was awarded contract HHSN27200010?

HHSN27200010 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 2, 2015.

How much is contract HHSN27200010 worth?

The government has obligated $2,549,095 on HHSN27200010.

Is contract HHSN27200010 an order under another contract?

Yes. HHSN27200010 is a delivery order under HHSN272201300022I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract HHSN27200010 competed?

The extent of competition for HHSN27200010 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login